Journal of Peking University(Health Sciences) >
Investigation of sleep disturbance and related factors in patients with primary Sjögren’s syndrome
Received date: 2020-07-13
Online published: 2020-12-13
Supported by
National Natural Science Foundation of China(31870879);National Natural Science Foundation of China(81701607)
Objective: To investigate the prevalence of sleep disorders and the relevant determinants in a cohort of primary Sj?gren’s syndrome (pSS) patients. Methods: One hundred and eighty-six pSS patients were included in the study, who were admitted to Peking University People’s Hospital and met the criteria of inclusion and exclusion. Sleep quality was assessed using the Pittsburgh sleep quality index(PSQI).Depression, anxiety were evaluated by patient health questionnaire (PHQ)-9,generalized anxiety disorder(GAD)-7, respectively. The demographic and clinical data were also recorded.Disease activity and damage were evaluated with the European League Against Rheumatism Sj?gren’s syndrome disease activity index (ESSDAI). According to the PSQI score>7, the pSS patients were divided into 152 cases of sleep disorder group and 34 cases of normal sleep group. Mann-Whitney U test, Chi-square test or Fisher’s exact test, independent samples t test, Spearman correlation analysis and Logistic regression were used for statistical analysis. Results: The prevalence of sleep disturbance (PSQI>7) was 81.7% (152 / 186) in the pSS patients, and 52.7% (98/186) had moderate or severe sleep disorders (PSQI≥11). The mean PSQI score of sleep disordered group was (12.29±3.30), while the normal sleep group PSQI score was (5.50±1.20). The PSQI score, PHQ-9 score and GAD-7 score in the sleep-disordered group were significantly higher than those in the normal sleep group (P=0.000, 0.035, 0.031). The PSQI score in the sleep disordered group were significantly higher than those in the normal sleep group in seven aspects: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disorders, hypnotic drug use and daytime dysfunction. All of them had statistical significance. According to the results of Spearman correlation analysis, PSQI had significantly positive correlation with course of disease, anxiety, depression score (r=0.151, 0.240, 0.421, P<0.05), but negatively correlated with C3,C4 (r=-0.021, -0.235, P<0.05). Logistic analysis identified the course of disease(OR=2.809, 95%CI: 1.21-6.52)and PHQ-9 score(OR=1.422, 95%CI: 1.04-1.94)as predictors of sleep disorders. Conclusion: The incidence of sleep disorder in the pSS patients was higher, which was closely related to the course of disease, anxiety, depression and other factors. It is critical to assess and manage comprehensively the disease.
Key words： Sj?gren's syndrome; Sleep disorders; Anxiety; Depression; Risk factors
Yi-fan WANG , Zhen FAN , Yao-bin CHENG , Yue-bo JIN , Yang HUO , Jing HE . Investigation of sleep disturbance and related factors in patients with primary Sjögren’s syndrome[J]. Journal of Peking University(Health Sciences), 2020 , 52(6) : 1063 -1068 . DOI: 10.19723/j.issn.1671-167X.2020.06.012
| [1] | Mariette X, Criswell LA. Primary Sj?gren’s syndrome[J]. N Engl J Med, 2018,378(10):931-939. |
| [2] | Cafaro G, Croia C, Argyropoulou Od, et al. One year in review 2019: Sj?gren’s syndrome[J]. Clin Exp Rheumatol, 2019, 37, 118(3):3-15. |
| [3] | Tsukamoto M, Suzuki K, Takeuchi T. Ten-year observation of patients with primary Sj?gren’s syndrome: Initial presenting characteristics and the associated outcomes[J]. Int J Rheum Dis, 2019,22(5):929-933. |
| [4] | Shen L, He J, Kramer JM, et al. Sj?gren’s syndrome: animal models, etiology, pathogenesis, clinical subtypes, and diagnosis[J]. J Immunol Res, 2019, 5(2019-05-20)[2020-04-10]. https://pubmed.ncbi.nlm.nih.gov/31236421. |
| [5] | Cui Y, Xia L, Li L, et al. Anxiety and depression in primary Sj?gren’s syndrome: a cross-sectional study[J]. BMC Psychiatry, 2018,18(1):131. |
| [6] | Milin M, Cornec D, Chastaing M, et al. Sicca symptoms are associated with similar fatigue, anxiety, depression, and quality-of-life impairments in patients with and without primary Sj?gren’s syndrome[J]. Joint Bone Spine, 2016,83(6):681-685. |
| [7] | Priori R, Minniti A, Antonazzo B, et al. Sleep quality in patients with primary Sj?gren’s syndrome[J]. Clinical and Experimental Rheumatology, 2016,34(3):373-379. |
| [8] | Tishler M, Barak Y, Paran D, et al. Sleep disturbances, fibro-myalgia and primary Sj?gren’s syndrome[J]. Clin Exp Rheumatol, 1997,15(1):71-74. |
| [9] | 中华医学会风湿病学分会. 干燥综合征诊断及治疗指南[J]. 中华风湿病学杂志, 2010,14(11):766-768. |
| [10] | Qin B, Wang J, Yang Z, et al. Epidemiology of primary Sj?gren’s syndrome: a systematic review and meta-analysis[J]. Ann Rheum Dis, 2015,74(11):1983-1989. |
| [11] | 李晏, 张胜利, 黄烽. 强直性脊柱炎患者睡眠质量及相关因素分析[J]. 中华风湿病学杂志, 2012,16(4):25l-254. |
| [12] | Lee YC, Chibnik LB, Lu B, et al. The relationship between disease activity, sleep, psychiatric distress and pain sensitivity in rheumatoid arthritis: a cross-sectional study[J]. Arthritis Res Ther, 2009,11(5):160. |
| [13] | Palagini L, Tani C, Mauri M, et al. Sleep disorders and systemic lupus erythematosus[J]. Lupus, 2014,23(2):115-123. |
| [14] | Mustafa M, Bawazir Y, Merdad L, et al. Frequency of sleep disorders in patients with rheumatoid arthritis[J]. Open Access Rheumatol, 2019,11:163-171. |
| [15] | Gudbjornsson B, Broman JE, Hetta J, et al. Sleep disturbances in patients with primary Sj?gren’s syndrome[J]. Br J Rheumatol, 1993,32(12):1072-1076. |
| [16] | Segal BM, Pogatchnik B, Henn L, et al. Pain severity and neuropathic pain symptoms in primary Sj?gren’s syndrome: A comparison study of seropositive and seronegative Sj?gren’s syndrome patients[J]. Arthritis Care Res(Hoboken), 2013,65(8):1291-1298. |
| [17] | Watson NF, Badr MS, Belenky G, et al. Recommended amount of sleep for a healthy adult: a joint consensus statement of the american academy of sleep medicine and sleep research society[J]. Sleep, 2015,11(6):591-592. |
| [18] | Usmani ZA, Hlavac M, Rischmueller M, et al. Sleep disordered breathing in patients with primary Sj?gren’s syndrome: A group controlled study[J]. Sleep Medicine, 2012,13(8):1066-1070. |
| [19] | Abad VC, Sarinas PS, Guilleminault C. Sleep and rheumatologic disorders[J]. Sleep Med Rev, 2008,12(3):211-228. |
| [20] | Walker J, Gordon T, Lester S, et al. Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sj?gren’s syndrome[J]. J Rheumatol, 2003,30(11):2406-2412. |
| [21] | Hackett KL, Gotts ZM, Ellis J, et al. An investigation into the prevalence of sleep disturbances in primary Sj?gren’s syndrome: a systematic review of the literature[J]. Rheumatology, 2017,56(4):570-580. |
| [22] | Theander L, Strombeck B, Mandl T, et al. Sleepiness or fatigue? Can we detect treatable causes of tiredness in primary Sj?gren’s syndrome?[J]. Rheumatology, 2010,49(6):1177-1183. |
| [23] | Ayaki M, Kawashima M, Negishi K, et al. Sleep and mood disorders in dry eye disease and allied irritating ocular diseases[J]. Sci Rep, 2016,6:22480. |
| [24] | Julich M, Budweiser S, Thoden J, et al. Sleep apnea in Sj?gren’s syndrome potentially influences the EULAR Sj?gren’s syndrome patient reported index[J]. Mod Rheumatol, 2019,29(3):563-565. |
| [25] | Hilditch CJ, McEvoy RD, George KE, et al. Upper airway surface tension but not upper airway collapsibility is elevated in primary Sj?gren’s syndrome[J]. Sleep, 2008,31(3):367-374. |
| [26] | Chung SW, Hur J, Ha YJ, et al. Impact of sleep quality on clinical features of primary Sj?gren’s syndrome[J]. Korean J Intern Med, 2019,34(5):1154-1164. |
| [27] | Meier-Ewert HK, Ridker PM, Rifai N, et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk[J]. J Am Coll Cardiol, 2004,43(4):678-683. |
| [28] | Emami Zeydi A, Jannati Y, Darvishi Khezri H, et al. Sleep quality and its correlation with serum C-reactive protein level in hemodialysis patients[J]. Saudi J Kidney Dis Transpl, 2014,25(4):750-755. |
| [29] | Ho KKN, Simic M, Smastuen MC, et al. The association between insomnia, C-reactive protein, and chronic low back pain: cross-sectional analysis of the HUNT study, Norway[J]. Scand J Pain, 2019,19(4):765-777. |
| [30] | Irwin MR, Olmstead R, Carroll JE. Sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation[J]. Biol Psychiatry, 2016,80(1):40-52. |
| [31] | Ranjbaran Z, Keefer L, Stepanski E, et al. The relevance of sleep abnormalities to chronic inflammatory conditions[J]. Inflamm Res, 2007,56(2):51-57. |
| [32] | Irwin MR, Wang M, Campomayor CO, et al. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation[J]. Arch Intern Med, 2006,166(16):1756-1762. |
| [33] | Bollinger T, Bollinger A, Skrum L, et al. Sleep-dependent activity of T cells and regulatory T cells[J]. Clin Exp Immunol, 2009,155(2):231-238. |
| [34] | Tripp NH, Tarn J, Natasari A, et al. Fatigue in primary Sj?gren’s syndrome is associated with lower levels of proinflammatory cytokines[J]. Rmd Open, 2016,2(2):e000282. |
/
| 〈 |
|
〉 |